AMINEX THERAPEUTICS
Aminex Therapeutics, Inc. is a drug development company focused on the discovery, development, and commercialization of suppressor cell modulators (SCM), a new class of small molecule cancer immunotherapies that enable the immune system to attack cancer by regulating myeloid-derived suppressor cells. Aminex has extensively demonstrated, in animal trials, the potential of its lead drug, AMX-513, to be effective alone and to improve overall therapy when used in combination with other cancer treatments. Aminex's vision is to make significant treatment contributions for a wide range of cancers and to ease the rising costs of cancer therapy.
AMINEX THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2009-01-01
Address:
Kirkland, Washington, United States
Country:
United States
Website Url:
http://www.aminextx.com
Total Employee:
1+
Status:
Active
Contact:
(425) 286-4222
Email Addresses:
[email protected]
Total Funding:
25.17 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag AJAX Libraries API GoDaddy SSL
Similar Organizations
ChemoCore Therapeutics
ChemoCore Therapeutics develops small molecule drugs.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.aminextx.com
- Host name: cloudproxy10170.sucuri.net
- IP address: 192.124.249.170
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
